Program
2003 Mid-Atlantic Venture Conference
Featuring BIO VentureForum East
| Monday, November 17 | ||
| 6:00 - 8:00 pm Grand Hall | Welcome Reception Sponsored by Cross Atlantic Capital Partners and Silicon Valley Bank | |
| Tuesday, November 18 | ||
| 7:30 am Grand Hall | Attendee Registration and Breakfast Exhibit Floor Opens | |
| 8:30 am Grand Ballroom | Welcome Remarks & Keynote Address Featuring Richard Karlgaard, Publisher, Forbes 20th Anniversary Recognition of Ben Franklin Technology PartnersSponsored by Ernst & Young | |
| 9:20 am - noon | Featured Company Presentations and Exhibits Presentation Schedule | |
| 9:50 am Room 203AB | Financing Strategies for Private Biotech FirmsSponsored by McCarter & English, LLP Panelists include Moderator: Jeff Baumel, Partner, McCarter & English LLP Vincent Milano, CFO, Viropharma Inc. P. Sherrill Neff, Managing Partner. Quaker BioVentures Keith Goldan, CFO, Biosyn Inc. Edward Rudnic, CEO, Advancis Eric Aguiar, Partner, Healthcare Ventures | |
| 12:15 - 1:30 pm Grand Ballroom | Luncheon & Keynote Address Featuring Dr. Stephen Oesterle, Sr. Vice President, Medicine and Technology, Medtronic, Inc. Sponsored by KPMG LLP | |
| 1:30 - 2:00 pm Grand Hall | Dessert Sponsored by Comerica Bank | |
| 2:00 - 4:30 pm | Featured Company Presentations and Exhibits Presentation Schedule | |
| 2:40 pm Room 203AB | Partnering Strategies and Deal Structures for Emerging Companies Panelists Include: Moderator: Neil Haimm, Drinker, Biddle & Reath LLP Christopher F. Reilly, VP, Head Global Discovery Venture, Advent International Ron Pepin, Sr. VP, Medarex Michael Lytton, Partner, Oxford Bioscience David King, CEO & President, Biorexus Inc. Robert Towarnicki, CEO & President, Nucleonics | |
| 6:00 - 9:00 pm Crystal Tea Room, Wanamaker Building | Gala Reception Sponsored by Grant Thornton and Pepper Hamilton LLP | |
| Wednesday, November 19 | ||
| 7:30 am Grand Hall | Attendee Registration and Breakfast Exhibit Floor Opens | |
| 8:30 am Grand Ballroom | Welcome Remarks, Keynote Address Featuring "The Future of Drug Development: A Perspective from R&D Executives" Sponsored by Safeguard Scientifics, Inc. Panelists include: C. Boyd Clark, President, CEO and Chairman, Neose Don Olsen, Director Licensing, J&J Ortho McNeil Herb Ormsbee Sr. Director Licensing & Business Development, Pfizer, Inc. Bruce Peacock, CEO & President, Adolor Barbara Yanni, Chief Licensing Officer, Merck & Co | |
| 9:30 am - 12:25 pm | Featured Company Presentations and Exhibits Presentation Schedule | |
| 9:40 am Room 203AB | Developing a Clinical Strategy Investors Will Love Panelist include: Moderator: Janice Hogan, Partner, Hogan & Hartson LLP Ken Carter, CEO and President, Avalon Pharmaceuticals Jane Hollingsworth, EVP, Co-Founder, Auxilium Pharmaceuticals Inc Elaine Jones, Partner, EuclidSR Partners Frederick Jones, MD, Asst. VP, Technology Licensing Global Business Development, Wyeth Mark McKinlay, Ph.D., VP R&D & Co-Founder, Viropharma Inc. | |
| 10:50 am Room 203AB> | M&A Financing Strategies Sponsored by Dorsey & Whitney LLP Panelists include: Moderator: Kevin Collins, Dorsey & Whitney LLP Doug Annett, President, Corporate Advisors Ltd. Geoff Cooper, VP Business Development, OSI Pharmaceuticals Inc. Sarajbit Ashta, Director, Corporate Development, Biogen Inc. Jonathan Leff, Partner, Warburg Pincus | |
| 12:15 - 1:30 pm Grand Ballroom | Luncheon & Keynote Address Featuring Dean Kamen, President, DEKA Research and Development Corporation | |
| 1:45 - 2:15 pm Grand Hall | Dessert Sponsored by Comerica Bank | |
© 2009 Biotechnology Industry Organization